July 31st, 2020
May 2020: A federal judge dismissed certain claims but allowed the false advertising claims to move forward. July 2019: The same named plaintiff, along with several other individuals, filed a class-action lawsuit against Johnson & Johnson in a New Jersey court similarly alleging that Tylenol® rapid release products do not work faster than non-rapid release
June 30th, 2020
June 2020: A federal court judge granted final approval of the settlement agreement. December 2019: A federal judge preliminarily approved the settlement agreement. A final fairness hearing is scheduled for June 22, 2020. For more information, go to http://www.infantstylenolsettlement.com/. September 2019: Plaintiffs moved for preliminary approval of a proposed settlement agreement. According to its terms,
October 28th, 2019
NAD inquiry finds supporting evidence lacking.
August 2nd, 2016
April 2015: This action was dismissed . The reasons for the dismissal have not been disclosed. March 2015: A class-action lawsuit was filed against Johnson & Johnson for allegedly misleadingly using ed packaging for Tylenol® pain reliever and fever reducer products. According to the complaint, the company uses containers that make it appear as if
September 23rd, 2013
A new in-depth report by ProPublica and This American Life is questioning Tylenol’s safety and labeling.
February 19th, 2021
February 2021: This case was transferred from a court in New York to one in Illinois. (Case No. 21-cv-856, N.D. Ill.) September 2020: A class-action lawsuit was filed against Walgreens for allegedly falsely marketing that its Fast-Release Quick Gels™ acetaminophen products are comparable to Tylenol® Extra Strength Rapid Release Gels when, according to plaintiffs, the
December 15th, 2020
Deceptive health and income claims, including some tied to COVID-19, persist in wake of warning from the feds.
November 10th, 2020
Lawsuits claim infant-specific products aren’t any different than acetaminophen medications for older children.
July 31st, 2020
September 2019: A federal judge dismissed certain claims but allowed the false advertising claims to move forward. November 2018: A class-action lawsuit was filed against Rite Aid for allegedly misleadingly marketing its Acetaminophen Rapid Release Gelcaps as being comparable to Tylenol® Extra Strength Rapid Release Gels when, according to plaintiffs, the Tylenol® Gels have “unique
July 31st, 2020
April 2019: A federal judge dismissed certain claims but allowed the false advertising claims to move forward. November 2018: A class-action lawsuit was filed against Walmart for allegedly misleadingly marketing its Equate™ Rapid Release products as being comparable to Tylenol® Extra Strength Rapid Release Gels when, according to plaintiffs, the Tylenol® products have “unique laser
January 24th, 2019
These claims are tough to swallow.
December 16th, 2013
Be careful, deceptive marketers — Santa was watching.